This work aim to provide an up-date of recent studies developed about the endocannabinoid system and neurological disorders. In the first instance, the modulation of this ubiquitary system in main neurological disorders will be discussed. Then except, most common cannabinoid drugs developed in the past years, more recent designed drugs will be discussed considering pros and cons of the application of these novel drugs in neurological disorders. Among these drugs, particular attention will be focused on compounds of organic synthesis and drug of peptide origin acting on cannabinoid receptors. Furthermore, an update on recent patented drugs selected for their applicability in central nervous system disorders will be highlighted. Finally, another chapter of this work will deal with the regulation by cannabimimetic drugs of the immune response in neurological disorders.
